1998; 1-81 drutz hp, appell ra, gleason d, klimberg i, radomski clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder. Triple treatment has a significant effect on global gene expression patterns Approximately one-third of the mouse genome is represented on the U74Av2 GeneChip, in 12422 probe sets. Of these, 6602 53.1% ; were expressed in whole mouse brain at a level sufficient to be called present in at least two out of 13 U95Av2 GeneChips, and were analysed further in this study. Pairwise comparisons of gene expression show that the largest number of differences was found between the WT and R6 2 mice and interestingly, those differences were substantially reduced in the R6 2 drug-treated mice compared to the WT drug-treated mice Fig. 4 ; . The false discovery rate based upon a comparison of the two samples with the greatest number of statistically altered genes was 22.5% at the P 0.05 level and 17.2% at the P 0.01 level. We thus considered in further analyses that for anova, using the information from all groups genes showing differential expression at P 0.01 would give an acceptable false discovery rate, for example, rxlist.

Tolterodine indications

Health & fitness healthcare center essentials illustrated health encyclopedia in depth reports care guides surgeries and procedures topics allergies arthritis asthma breast cancer cancer deafness dermatology diabetes headaches heartburn heart disease depression ibs crohn's disease mental health men's health nutrition senior health stress weight loss women's health tools about video library drug finder find a doctor find a hospital medical encyclopedia symptom checker latest articles help diseases a-z read more movement - unpredictable or.
St John's wort An American laboratory study has found that a protein in the herbal antidepressant St John's wort is able to inhibit the replication of HIV. The results of this study were picked up by some of the popular media and misrepresented. In particular, it should be noted that St John's wort has an interaction with protease inhibitors resulting in low levels of anti-HIV drugs in the blood which could lead to the development of drug resistant HIV. The American researchers who conducted the study also warn against taking St John's wort tablets bought over the counter as an HIV treatment. They emphasise that their study was conducted in a laboratory and the same results might not be produced in humans. They also caution, "even if the [anti-HIV] protein were available in [St John's wort] tablets, we don't know how much might be present and whether the protein would be effective." It makes good sense to talk to your HIV doctor or another member of your HIV healthcare team about any drugs you are taking in addition to drugs prescribed by them. This includes complementary, herbal and alternative treatments, medicines bought over the counter from chemists, and recreational drugs, for example, tolterodine 2 mg.
Dagger; pharmacokinetics in special populations age in phase 1, multiple-dose studies in which tolterodine immediate release 4 mg 2 mg bid ; was administered, serum concentrations of tolterodine and of the 5-hydroxymethyl metabolite were similar in healthy elderly volunteers aged 64 through 80 years ; and healthy young volunteers aged less than 40 years.

Tolterodine brand

It is helpful if the doctor is familiar with both vascular and neuro-musculoskeletal medicine and gliclazide. Research and development programs of the type conducted by the Institute require extensive regional and international collaboration. In 1999 2000 the Institute's research program was conducted in collaboration with more than 200 universities and hospitals in over 12 countries worldwide. Major collaborative relationships have been established in Asia, North America and Europe with research centres with particular interests in heart and vascular disease, injury or health care in developing or newly industrialised countries. The Institute is also involved in collaborative programs with the World Health Organization and the Global Forum for Health Research. Regionally, major collaborative relationships have been established with the University of Melbourne, the University of Auckland, the Australia and New Zealand Intensive Care Society and with several centres in Sydney including the NHMRC Clinical Trials Centre University of Sydney ; and the Injury Risk Management Research Centre University of New South Wales.
Notes to Consolidated Financial Statements Pfizer Inc and Subsidiary Companies day marketing exclusivity period. Any launches of generic gabapentin products during this period would still be subject to our patents, even though the stay has expired. Lipitor atorvastatin ; A generic manufacturer filed an abbreviated new drug application with the FDA for atorvastatin Lipitor ; in 2002 and amended the application in early 2003 to allege that its product would not infringe our basic product patent for atorvastatin. Shortly thereafter, the generic manufacturer also asserted that our patent covering the active enantiomeric form of the drug is invalid. In 2003, we filed suits in the U.S. District Court for the District of Delaware against the generic manufacturer for infringement of both our basic product patent and our patent covering the active enantiomeric form of the drug. The trial of this matter has been scheduled for November 30, 2004. Our basic product patent, including the additional six-month pediatric exclusivity period, expires in 2010. Our enantiomer patent, including the six-month pediatric exclusivity period, provides one additional year of protection, expiring in 2011. Diflucan fluconazole ; Our basic product patent for fluconazole Diflucan ; expired in January 2004. As a result, the patent infringement suit that we filed against a generic manufacturer in May 2002 in the U.S. District Court for the District of New Jersey became moot, and a stipulation of dismissal has been entered. The FDA has granted us pediatric exclusivity with respect to Diflucan, which extends our marketing exclusivity for six months after the patent expiration date, through July 29, 2004. One of the generic manufacturers that has filed an abbreviated new drug application for fluconazole has brought an action against the FDA challenging the grant of pediatric exclusivity. A hearing on this matter is scheduled for March 4, 2004. If that challenge is successful, our sales of Diflucan could be subject to competition from generic fluconazole products immediately. Xalatan latanoprost ; In November 2001, a generic manufacturer notified Pharmacia that it had filed an abbreviated new drug application with the FDA seeking approval to market a product containing latanoprost, which Pharmacia markets as Xalatan. In December 2001, Pharmacia filed suit against the generic manufacturer in the U.S. District Court for the District of New Jersey alleging infringement of various patents relating to latanoprost that are held by or licensed to Pharmacia. The generic manufacturer has admitted infringement but claims that these patents are invalid and unenforceable. The trial of this matter is scheduled for March 15, 2004. Detrol tolterodine ; In February 2004, a generic manufacturer notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market tolterodine Detrol ; . We intend to file a patent infringement suit against the generic manufacturer and dibenzyline.
An 85 year old man with glaucoma and a colostomy was admitted to a medical ward for investigations. During his stay, his stomal deodorant drops were inadvertently instilled into both eyes instead of topical glaucoma treatment. Despite immediate and intensive ocular irrigation, the deodorant drops, which had a pH of 5, caused severe chemical injury to both eyes, including loss of both corneal epithelia and 180 of limbal ischaemia in the left eye. He eventually made a full recovery. Great care must be taken when patients need ocular treatments in addition to other treatments contained in dropper bottles.

1999. Robert Wood Johnson Foundation. 1996-2003. 12. Beatty WK. Galen. Of protecting the Health, book V. In: Sleep and phenoxybenzamine. Opioid is more general, referring to any drug that acts on the opioid receptor. Few studies have directly evaluated the efficacy of oxybutynin and tolterodine in comparable formulations, and differing study designs and measures of symptom improvement prevent confident comparisons and phenytoin. From 1995 to 1998, Mexico experienced impressive growth in the number and diversity of products and active ingredients authorised as non- prescription medicines. During this period, the Mexican Ministry of Health authorised the switching of at least 200 non-prescription products and those active ingredients known as " second. Sales of DXP in Sweden It was mentioned above that products containing DXP have been among the most widely sold analgesics since the 1970s. Table 2 shows sales in the 1990s and valsartan. Flavoxate Urispas ; oxybutynin Ditropan ; ? tolterodine Detrol ; tolterodine LA Detrol LA.
Large measure on saquinavir pharmacokinetics and nevirapine. Tags : affliction , health , pain comments » trackback url: site : : cool, still waters : : : healing hands : : pastilla 2005 06 25 selva, for example, tolterodine tartate.
Your pharmacist has information about tolterodine written for health professionals that you may read and didanosine. Camomile 03 08 04 mediastar, the only medications i know off for over active bladder which are either an antispasmodic or anticholinergic, oxybutynin, oxybutynin modefied release also known as cystrin or ditropan , detrusitol, detrusitol xl also known as tolterodine, propiverine also known as detrunorm, trospium chloride also known as regurin, and flavoxate also known as urispas. You, or your partner, are known to be HIV positive. You, or your partner, have ever injected yourselves with drugs. You, or your partner, have been advised not to give blood. You, or your partner, have had tattoos, acupuncture, or body piercing performed. You, or your partner, have haemophilia or a related blood clotting disorder needing clotting factor concentrates and videx.
Stimulants, 16.4 percent were anticonvulsants mood stabilizers ; and 12.6 percent were other attention deficit and hyperactivity disorder ADHD ; drugs. Another 1.2 percent were anxiolytics, 1.0 percent were hypnotics sedatives and 0.9 percent were antidyskinetics, which are used to control the side effects of antipsychotic drugs. Exhibits 2 and 3 ; . Other studies of medications given to Medicaid or foster care children have tended to. Key words phrases: patient charges, health care system, decision-making, prescribing and digoxin and tolterodine, for example, drug interactions. TABLE 31. Overview of recent evidence for candidate genes for bipolar disorder continued. Immediate-release oxybutynin and tolterodine the most popular options ; are equally effective, but tolterodine has a better side effect profile and dipyridamole. By Tom Fincher, Director , Employee Support Services n recent remarks to SCDOT senior managers, Executive Director Elizabeth Mabry said, "I responsible for SCDOT and everything that is in it." In so doing, Mabry hit upon an eternal truth of all leaders. Look at it this way. A leader or manager is responsible for everything his or her organization does or fails to do. Though expressing it differently, Mabry said the same thing. While she is responsible for SCDOT and everything in it, Mabry cannot possibly do everything that needs doing in the Department. She must, quite properly, depend on others to assist her. In doing so, can she delegate some of her responsibilities? The answer is NO! A leader or manager cannot delegate responsibility. What they can and should do is delegate authority. If one's responsibility is delegated, then accountability becomes fragmented and blurred. Mabry depends on her deputy directors and other leaders and managers to assist her in managing SCDOT. She gives them their own set of responsibilities and delegates to them authority to carry out those responsibilities. But in doing so, she still remains "responsible for SCDOT and everything in it." That is why the responsibilities of leaders are so important. Everyone in an organization should have their own set of responsibilities and be accountable for carrying them out. These subordinate leaders, like the leader at the top, cannot delegate their responsibilities either. Being responsible is a big responsibility. Because of their precise targets, these drugs do not damage the entire immune system the way that general immunosuppressants do.
Antiarrhythmic drugs. Although some of these drugs do carry a substantial risk of causing torsades de pointes, others lengthen the QT interval markedly but do not lead to torsades de pointes. The risk for QT prolongation and torsades de pointes varies substantially among drugs. Antiarrhythmic drugs are often used by electrophysiologists and cardiologists to treat conditions serious enough to warrant their associated risk. The risk may exceed the benefit, however. Quinidine, a treatment for atrial fibrillation, for example, is now rarely used because of its effect on QT interval length. The QT interval can also be prolonged by drugs such as antidepressants, antipsychotics, antimicrobials, antimalarials, antimycotics, antihistamines, vasodilators, and antianginals. While many types of drugs can prolong the QT interval, this is not necessarily a drug class effect. It is possible that one antimuscarinic drug, for example, could prolong the QT interval but another may not. In cases in which a selection of equally effective agents within a class are available, it is prudent to select drugs that are least likely to prolong the QT interval. Notably, several drugs have been removed from the market due to the risk of torsades de pointes and death. These include: mibefradil, 32 terfenadine, 33 cisapride, 34 astemizole, 35 bepridil, 36 grepafloxacin, 37 and notably, terodiline, an antimuscarinic drug.38-41 Terodiline caused roughly 50 episodes of torsades de pointes, not as a result of its antimuscarinic activity, but predominantly because of its actions on IKr.42 Of note, terodiline lengthened the QT interval by only 15 ms, within the FDA gray zone for concern with regard to torsades de pointes. Clearly, not all antimuscarinic agents block sodium, calcium, and chloride channels, nor do they all lead to torsades de pointes. One clear disadvantage in attempting to understand the effects of antimuscarinic drugs on QT interval prolongation, however, is that there is a lack of carefully controlled clinical trials comparing these agents to each other. Further, there are no outcomes data demonstrating specific clinical implications of QT interval prolongation by an antimuscarinic drug. Among the agents approved for treatment of OAB, one study examined the cardiac effects of oxybutynin in 21 elderly patients at a mean dose of 7.6 mg range, 2.5-10 ; . In this study, oxybutynin did not prolong the QTc interval.43Although the difference from baseline did not reach statistical significance, the mean decrease in QTc was 9 ms, and increase in the QT interval was 9 ms. Extensive and definitive clinical studies of the effects of oxybutynin on the QT interval are lacking. Oxybutynin also appears to have relatively minor effects on cardiac ion channels. 44 Another agent approved for the treatment of OAB, tolterodine, is known to potently inhibit the IKr channel.45 No clinical data demonstrate QT interval prolongation because of treatment with tolterodine, but extensive clinical investigation of this issue is lacking. Among the OAB agents that have been investigated for effects on the QT interval, solifenacin has been reported to cause an 8-ms increase in the corrected QT interval at the 30-mg dose, although there are not adequate data reported in the literature to. 5. the disadvantages and advantages of HRT, including an understanding of the effects on osteoporosis, atheroma and atrophy Advantages: 1. Relieves hot flushes, sleep disturbance, vaginal dryness, some urinary incontinence, skin changes, some psychological manifestations and treats vaginal atrophy 2. E can prevent osteoporosis by decreasing loss of trabecular .bone and by even increasing specific bone density. All women, .and pecially .those at high risk for osteoporosis slim, Caucasian Oriental; sedentary, smoker, lifelong dietary Ca2 + deficiency ; should be counselled on the beneficial effects of HRT on osteoporosis which can prevent the consequences of decreased bone density and the associated morbidity and mortality i.e. fractures - esp hip and vertebral ; . 3. After menopause, and in women who have had premature loss of their ovaries without replacement estrogen management, the risk of CAD increases dramatically. The lipid profile changes with these women showing increased levels of cholesterol, triglycerides, LDL and decreased levels of HDL, compared to previous states of ovarian function. HRT has a proven benefit in dramatically lowering the incidence of CAD, the morbidity and mortality associated with it, and in preventing slowing the progression of established disease. HRT results in: a ; improved cholesterol profile: total cholesterol, LDL and LP A ; an independent risk factor for CAD involved in arterial wall and reverse cholesterol transport ; incr HDL also increased triglycerides ; b ; blocking of the development of atherosclerosis c ; Indirect promotion of vasodilatation. d ; other benefits: decr BP, glucose insulin levels Since CAD is the #1 killer of postmenopausal women, having a death rate l0x that of breast cancer, the effects of HRT on CAD are extremely important and must be conveyed to the patient. 4. If on combination HRT E + P ; - decreased risk of endometrial cancer. Disadvantages: 1. Excess E may cause breast tenderness, increased vaginal secretions: if unopposed, increased risk of endometrial cancer. 2. P may cause PMS-like symptoms if given cyclically e.g. mood changes, east tenderness, menstrual cramps, headaches. ; 3. In a small percentage of women taking oral HRT, BP may increase due to the steroids affecting the liver's metabolism of renin. Transdermal route avoids this. HRT IS NOT ASSOCIATED WITH INCREASED RISK OF: thrombosis cervical cancer ovarian cancer breast cancer if 8 yrs of HRT; longterm treatment may be associated with a very slight increase 6. anticipatory guidance for women approaching the climacteric stage: It is extremely important to counsel women that the changes which occur at menopause should not be dealt with only at that time, but that a healthy lifestyle should be instituted prior to menopause in order to minimize the deleterious physical changes that occur. To maintain bone density as much as possible, adequate Ca2 + intake should be a priority throughout life, not just after menopause. Regular exercise which is weight bearing and vigorous is also important to strengthen bone as well as to provide for cardiovascular fitness. Women should be advised that excess salt, caffeine, EtOH and protein as well as certain drugs, for instance, medications. Qty get up to a month supply and avoid the hassles of driving, parking and long waits standing in lines to overpay at your local pharmacy and gliclazide.

Tolterodine overdose

Anticholinergic antispasmodics: belladonna alkaloids, butylscopolamine, tolterodine, trospium, oxybutynin, isometheptene, drofenine. Anticholinergics: biperiden. With the reconstituted vitamin D3 25-hydroxylase system contained 0.1-0.25 nmol of CYP2D25, 2 units of NADPH-cytochrome P450 reductase and 0.5 mg of NADPH in a total volume of 250 l of 100 mM PO4 buffer, pH 7.4. The incubations were terminated by addition of 125 l of acetonitrile and the mixtures were analyzed for product formation by HPLC as described 17 ; . The enzymatic product formed had the same retention time as the authentic 5-hydroxymethyl metabolite of toolterodine 17.
Testolactone.43 testosterone .34 TESTRED.34 tetracycline hcl .37 Tetracyclines.36 TEV-TROPIN .30 THALITONE .21 thalomid .37 THALOMIDE .37 THEO-24 .14 THEOBID.14 THEOCAP .14 THEOLAIR .15 theophylline anhydrous .14 thiabendazole.38 Thiazide and Related Diuretics .21 thioguanine.43 thioridazine hcl .17 thiothixene .17 thyroid.31 Thyroid Hormones.30 tiagabine hcl .46 TICLID.33 ticlopidine hcl.33 TIKOSYN.18 TILADE .14 timolol.32 timolol maleate .19, 32 TIMOPTIC .32 TIMOPTIC-XE.32 tiotropium bromide .14 tipranavir.39 tizanidine hcl .47 TOBRADEX .31 tobramycin sulfate.32 tobramycin sulfate dexameth .31 TOBREX.32 TOFRANIL.16 tolazamide.28 tolbutamide.28 tolteeodine tartrate .49 TOPAMAX.46 Topical Antibiotics .24, 26 Topical Antibiotics Anti-Inflammatory, Steroidal .26 Topical Antifungals.25 Topical Anti-Inflammatory Steroidal .25 Topical Antineoplastic and Premalignant Lesion Agents .26 Topical Antiparasitics.25 Topical Antivirals .25 Topical Hyperpigmentation Agents.27 Topical Immunosuppressive Agents .27 Topical Local Anesthetics .26 Topical Preparations, Antibacterials.24 Topical Sulfonamides .25 TOPICORT.25 TOPICORT LP.25 topiramate .46 TOPROL XL .19 62. Beoordeeld door klinische experts. Eveneens werden de scores van de parate kennis toets en ingevulde vragenlijsten verzameld. Tijdens de Praktijkoefening beheersten de 2e, 3e en 4e jaars studenten de vaardigheid `Het kiezen van de medicamenteuze ; behandeling' op respectievelijk 43.3, 45.0 en 51.0% van het vereiste basisartsniveau. Op de Praktijktoets was het beheersingsniveau 63.9%. Dit niveau was significant lager dan dat van de groep 6e jaars studenten 72.6%: zie hoofdstuk 3 ; die het context-gebonden programma niet hadden gevolgd. Tijdens de Praktijkoefening beheersten de 2e, 3e en 4e jaars studenten de cognitieve vaardigheid `Het bepalen van de informatie voor de patint' op respectievelijk 47.3, 47.2 en 45.3% van het vereiste basisartsniveau. Op de Praktijktoets was het niveau 69.0% en dit niveau was significant hoger dan het niveau van de groep 6e jaars studenten 43.6%, zie hoofdstuk 3 ; . Aangaande de parate kennis toets was de goed-min-fout score van de 2e, 3e en 4e jaars studenten respectievelijk 30.1, 41.8 en 44.8% van de maximale score. De score van de 3e jaars studenten was aanzienlijk hoger dan die van de 2e jaars. De studenten besteedden gemiddeld 1% van de totale studietijd aan het farmacotherapie programma. De waardering voor de Praktijkoefening door de studenten was van 78 82% van de maximaal haalbare waardering en voor de Praktijktoets 99%. De conclusie van het onderzoek is dat het beheersingsniveau van de cognitieve vaardigheden steeg bij 2e-4e jaars studenten omdat zij het context-gebonden farmacotherapie programma hadden gevolgd. Het niveau van de 4e jaars studenten tijdens de Praktijktoets is vergelijkbaar met dat van eerder geteste 6e jaars studenten, die het context-gebonden onderwijs niet hadden gevolgd maar wel de co-assistentschappen. Dit resultaat werd bereikt met een minimum aan studiebelasting en een maximum aan waardering door de studenten voor de context-gebonden onderwijsmethode, waarbij de setting zo veel mogelijk leek op de echte praktijk. In het laatste hoofdstuk, Algemene Beschouwing, worden de resultaten van de vier onderzoeken besproken aan de hand van een toetsingsmodel. In dit model worden vier lagen onderscheiden: feitenkennis; toepassen van deze kennis in.
Approved by the fda to decrease the incidence of infection, as manifested by febrileneutropenia, in patients with non-myeloid malignancies receiving myelosuppressiveanticancer drugs associated with a clinically significant incidence of febrile neutropenia, for example, pharmacokinetics. PROGESTINS $10 medroxyprog acetate Provera ; $30 norethindrone acetate Aygestin ; $45 medroxyprog Depo-Provera ; CKPA ESTROGEN PROGESTIN $25 est med Prempro, Premphase ; ESTROGEN ANDROGEN $25 est estrog methyltest Estratest ; OTHER HORMONES $75-150 desmopressin DDAVP Tablet ; $75-150 desmopressin DDAVP Nasal ; # XII. OBSTETRICAL GYNECOLOGIC VAGINAL ANTI-FUNGALS $10 nystatin tabs Mycostatin vaginal ; $10 clotrimazole Gyne-Lotrimin ; $15 miconazole Monistat ; $15 butoconazole Femstat ; $30 terconazole Terazol ; $35 metronidazole Metrogel ; # $35-40 clindamycin Cleocin ; ORAL CONTRACEPTIVES Any FDA-approved contraceptive EMERGENCY CONTRACEPTIVES $15 Preven Kit w pregnancy test ; # OXYTOCICS $10-15 methylergonovine Methergine ; XIII. UROLOGICS ANTISPASMODICS $10-15 bethanechol Urecholine ; $10-20 oxybutynin Ditropan ; $100 trospium Sanctura ; # $105-120 tollterodine Detrol, Detrol LA ; # $110 oxybutynin Ditropan XL, Oxytrol ; # $115 solifenacin Vesicare ; # $110 darifenacin Enablex ; # BPH AGENTS $55 tamsulosin Flomax ; # $80 finasteride Proscar ; # $95 dutasteride Avodart ; # OTHER UROLOGICS $5 phenazopyridine Pyridium ; # XIV. GASTROINTESTINAL Restricted to CalOptima Plan Gastroenterologist ANTI-DIARRHEALS $5 loperamide Imodium ; $5-10 diphenoxylate atropine Lomotil ; $10 belladonna pb Donnatal ; $10 paregoric $50 opium tincture Effective 5 01 07. Extended Release vs.Immediate Release ER vs IR ; Oxybutynin ER v Tolferodine IR Appell 2001 USA. 1 Institute for Environmental Studies, Department of Chemistry, University of South Florida, Tampa, FL 33620. 2 Current address: Laboratory of Molecular Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709. 3 Environmental Section, Southwest Florida Water Management District, 2379 Broad Street, Brooksville, FL 34604. 4 Corresponding author. Received for publication March 16, 2002 and in revised form May 23, 2002.

Tolterodine detrol la

These reactions are three times more prevalent with oxybutynin ir than with either oxybutynin xl or tolterodine. Evaluations and consultations; treatment objectives; discussion of risks and benefits; treatments; Medications including date, type, dosage, and quantity prescribed instructions and agreements; and periodic reviews. Records should remain current and be maintained in an accessible manner and readily available for review. 7. Compliance with Controlled Substances Laws and Regulations To prescribe, dispense, or administer controlled substances, the physician must be licensed in the province and comply with the applicable legislation. For more information refer to the Controlled Drugs and Substances Act for the federal law governing controlled substances as well as the Narcotic Control Regulations and related regulations. Note: Full text may be found at nmb PolicyDocument ?ID 8. Stable sustained release compositions providing a dissolution profile with reduced dependency on the gastrointestinal ph- value and ionic strength were described in patent application ep 1 629 83 they comprise core formulations containing tolterodine and a binder.

Detrol la tolterodine l-tartrate

In the past, and particularly during 1980s, the essential drugs list of bangladesh included some 200 products.

Tolterodine prescription

Hypermobility syndrome diet, low testosterone in women, jugular thrombosis in horses, mendelian rain lyrics and circulation qc. Baseline filmtracker, human cloning moral issues, marfan syndrome journal and allele expressed in heterozygote or dissociation reaction for ch3cooh.

Tolterodine anticholinergic

Tolterodine indications, tolterodine brand, tolterodine overdose, tolterodine detrol la and detrol la tolterodine l-tartrate. Tolteroidne prescription, tolterodine anticholinergic, tolterodine tartrate generic and tolterodine pharmacodynamics or tolterodine tablets.

© 2007-2009 Online-low.ueuo.com -All Rights Reserved.